FDA inspection
Cadila Pharmaceuticals Limited: FDA inspection ending Jan 20, 2023
FDA inspection 1195397 · Voluntary Action Indicated (VAI) · Ankleshwar
Key facts
| Inspection ID | 1195397 |
|---|---|
| Firm | Cadila Pharmaceuticals Limited |
| FEI number | 3014078015 |
| Address | 3203, G.I.D.C. Industrial Estate |
| City | Ankleshwar |
| Fiscal year | 2023 |
| Inspection end date | Jan 20, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data